These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 15955719)

  • 1. Gene therapy in the cornea.
    Mohan RR; Sharma A; Netto MV; Sinha S; Wilson SE
    Prog Retin Eye Res; 2005 Sep; 24(5):537-59. PubMed ID: 15955719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospects for gene therapy in corneal disease.
    Jun AS; Larkin DF
    Eye (Lond); 2003 Nov; 17(8):906-11. PubMed ID: 14631395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corneal gene therapy.
    Klausner EA; Peer D; Chapman RL; Multack RF; Andurkar SV
    J Control Release; 2007 Dec; 124(3):107-33. PubMed ID: 17707107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospects for genetic modulation of corneal graft survival.
    Williams KA; Brereton HM; Coster DJ
    Eye (Lond); 2009 Oct; 23(10):1904-9. PubMed ID: 19098707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental gene transfer to the corneal endothelium.
    Kampik D; Ali RR; Larkin DF
    Exp Eye Res; 2012 Feb; 95(1):54-9. PubMed ID: 21777585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latest developments in gene transfer technology: achievements, perspectives, and controversies over therapeutic applications.
    Romano G; Michell P; Pacilio C; Giordano A
    Stem Cells; 2000; 18(1):19-39. PubMed ID: 10661569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of local and systemic viral interleukin-10 gene transfer on corneal allograft survival.
    Gong N; Pleyer U; Volk HD; Ritter T
    Gene Ther; 2007 Mar; 14(6):484-90. PubMed ID: 17093506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of interleukin-12p40 gene transfer on rat corneal allograft survival.
    Ritter T; Yang J; Dannowski H; Vogt K; Volk HD; Pleyer U
    Transpl Immunol; 2007 Nov; 18(2):101-7. PubMed ID: 18005852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gene therapy in corneal diseases].
    Hoffmann F; Junghans C
    Klin Monbl Augenheilkd; 2003 Nov; 220(11):731-7. PubMed ID: 14634900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lentivirus-mediated gene transfer to the rat, ovine and human cornea.
    Parker DG; Kaufmann C; Brereton HM; Anson DS; Francis-Staite L; Jessup CF; Marshall K; Tan C; Koldej R; Coster DJ; Williams KA
    Gene Ther; 2007 May; 14(9):760-7. PubMed ID: 17301843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gene therapy in ophthalmology. Review of options and trends in corneal diseases].
    Pleyer U; Dannowski H; Reszka R; Volk HD; Hartmann C; Ritter T
    Klin Monbl Augenheilkd; 2001 Mar; 218(3):140-7. PubMed ID: 11322050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the chemokine antagonist vMIP II using a non-viral vector can prolong corneal allograft survival.
    Pillai RG; Beutelspacher SC; Larkin DF; George AJ
    Transplantation; 2008 Jun; 85(11):1640-7. PubMed ID: 18551072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential of viral vector-mediated gene transfer to prolong corneal allograft survival.
    Parker DG; Brereton HM; Coster DJ; Williams KA
    Curr Gene Ther; 2009 Feb; 9(1):33-44. PubMed ID: 19275570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tendon healing in vitro: bFGF gene transfer to tenocytes by adeno-associated viral vectors promotes expression of collagen genes.
    Wang XT; Liu PY; Xin KQ; Tang JB
    J Hand Surg Am; 2005 Nov; 30(6):1255-61. PubMed ID: 16344185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphoproliferative disorders: prospects for gene therapy.
    Larsen SR; Rasko JE
    Pathology; 2005 Dec; 37(6):523-33. PubMed ID: 16373231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is ex vivo adenovirus mediated gene transfer a therapeutic option for the treatment of corneal diseases?
    Ritter T; Gong N; Pleyer U
    Br J Ophthalmol; 2005 Jun; 89(6):648-9. PubMed ID: 15923492
    [No Abstract]   [Full Text] [Related]  

  • 17. Gene therapy for neurodegenerative and ocular diseases using lentiviral vectors.
    Ralph GS; Binley K; Wong LF; Azzouz M; Mazarakis ND
    Clin Sci (Lond); 2006 Jan; 110(1):37-46. PubMed ID: 16336203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of corneal neovascularization with endostatin delivered by adeno-associated viral (AAV) vector in a mouse corneal injury model.
    Lai LJ; Xiao X; Wu JH
    J Biomed Sci; 2007 May; 14(3):313-22. PubMed ID: 17373573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modalities and future prospects of gene therapy in heart transplantation.
    Vassalli G; Roehrich ME; Vogt P; Pedrazzini GB; Siclari F; Moccetti T; von Segesser LK
    Eur J Cardiothorac Surg; 2009 Jun; 35(6):1036-44. PubMed ID: 19318274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase 14 overexpression reduces corneal scarring.
    Galiacy SD; Fournié P; Massoudi D; Ancèle E; Quintyn JC; Erraud A; Raymond-Letron I; Rolling F; Malecaze F
    Gene Ther; 2011 May; 18(5):462-8. PubMed ID: 21160532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.